NCT03787251 2022-04-19A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With ApatinibThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 2 Withdrawn